Last reviewed · How we verify
NCT04085640: NOCH
Obturator Nerve Block in Total Hip Arthrosplasty
NA trial testing Obturator nerve block with ropivacaine 0.2%. in Primary Total Hip Arthroplasty in 60 participants. Completed in 22 September 2020.
22 September 2020
Quick facts
| Lead sponsor | Clinique Medipole Garonne |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 14 January 2020 |
| Primary completion | 22 September 2020 |
| Estimated completion | 22 September 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Obturator nerve block with ropivacaine 0.2%.
- Obturator nerve block with isotonic saline
Conditions studied
- Primary Total Hip Arthroplasty — all drugs for Primary Total Hip Arthroplasty →
Sponsor
Clinique Medipole Garonne
Who can join
18 and older, any sex, with Primary Total Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Interest of obturator nerve block for analgesia in total hip arthroplasty remains controversial. This regional anesthesia procedure could provide post-operative pain relief as obturator nerve is responsible for innervation of the internal part of the hip joint capsule. This randomized double-blind study aims to assess obturator nerve block for post-operative analgesia in total hip arthroplasty. Before the surgery, an ultrasound guided obturator nerve block will be performed with either 20cc of saline or ropivacaine 0.2% (a long-acting local anesthetics). After regional anesthesia, a general anesthesia will be performed for intraoperative period. This study aims to assess post-operative pain management during the first 24 hours. Ability to walk the day of the surgery will also be collected.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Obturator nerve block does not provide analgesic benefits in total hip arthroplasty under multimodal analgesic regimen: a randomized controlled trial.
Marty P, Chassery C, Rontes O, Vuillaume C, et al · · 2021 · cited 7× · PMID 33952684 · DOI 10.1136/rapm-2021-102531
Verify or expand the search:
- PubMed search for NCT04085640
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Primary Total Hip Arthroplasty
Currently open trials in the same condition.
- NCT07337642 — Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty · NA · recruiting
Other Clinique Medipole Garonne trials
Trials by the same sponsor.
- NCT04499716 — Quadriblock Versus "IPACK + Femoral Triangle Block + Obturator Nerve Block" in Total Knee Arthroplasty · NA · completed
- NCT04436861 — the Health Crisis at the Healthcare Professionals, Careers and Non-careers, a Month After the Containment Period · withdrawn
- NCT03195426 — A Diaphragm-Sparing Nerve Block for Arthroscopic Shoulder Surgery? · NA · completed
- NCT03192865 — Diaphragmatic Paralysis in Arthroscopic Shoulder Surgery · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04085640 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinique Medipole Garonne
- Last refreshed: 14 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04085640.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing